CERS
CERUS CORP
NASDAQ · Healthcare · Medical - Devices · US
$2.65
−0.38%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 104.20x
- P/S forward
- 2.02x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.63x
- Price / sales
- 2.41x
- Price / cash flow
- 220.95x
Enterprise value
- Enterprise value
- $555.3M
- EV / sales
- 2.51x
- EV / EBITDA
- 190.94x
- EV / EBIT
- -343.39x
- Market cap
- $534.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026